Sareum Holdings (SAR)

 

SAR Share PerformanceMore

52 week high1.7250 28/09/16
52 week low0.5574 26/07/16
52 week change 0.1350 (17.65%)
4 week volume135,705,978 28/03/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Director Deals - Sareum Holdings PLC (SAR)

Dr Stephen Parker, Chairman, bought 1,136,221 shares in the company on the 8th March 2017 at a price of 0.95p. The Direct...

Director Shareholding

RNS Number: 9294Y Sareum Holdings PLC 09 March 2017 (AIM: SAR) 9 March 2017 SAREUM HOLDINGS PLC ("Sareum" or "the Company") Director shareholding Sareum announces that Dr. Stephen Parker, Sareum's Chairman, and his wife purchased 461,949 and 674,272 shares at 0.95p each respectively yesterday. These are the only shares that Dr Parker or his ...

Sareum swings to H1 pretax profit

Sareum Holdings has swung to an H1 pretax profit of 573,000, from a year-ago loss of 568,000. Revenue was nil. "With Chk...

Half-year Results

RNS Number: 2451X Sareum Holdings PLC 20 February 2017 (AIM:SAR) 20 February 2017 SAREUM HOLDINGS PLC ("Sareum" or "the Company") HALF-YEARLY RESULTS FOR THE SIX MONTHS ENDED 31 DECEMBER 2016 Sareum Holdings plc (AIM: SAR), the specialist cancer drug discovery and development business, announces its half-yearly results...

Notice of Interim Results

RNS Number: 3549W Sareum Holdings PLC 09 February 2017 (AIM: SAR) 9 February 2017 SAREUM HOLDINGS PLC ("Sareum" or "the Company") Notice of Interim Results Sareum Holdings plc (AIM:SAR), the specialist cancer drug discovery and development company, announces that it expects to release its interim results for the six months to 31 December 2016...

Milestone Payment from Chk1 Licence Agreement

RNS Number: 6485T Sareum Holdings PLC 09 January 2017 (AIM: SAR) 9 January 2016 SAREUM HOLDINGS PLC ("Sareum" or "the Company") Milestone Payment from Chk1 Licence Agreement Sareum Holdings plc (AIM:SAR), the specialist cancer drug discovery and development company, is pleased to announce the attainment of a US$2.0 million success mile...

Result of General Meeting

RNS Number: 6018S Sareum Holdings PLC 22 December 2016 SAREUM HOLDINGS PLC ("Sareum" or "the Company") Result of General Meeting Sareum (AIM: SAR), the specialist cancer drug discovery and development business, announces that at the General Meeting held earlier today, the resolution was duly passed. For further information: Sareum Holdings p...

Result of AGM

RNS Number: 9697R Sareum Holdings PLC 15 December 2016 SAREUM HOLDINGS PLC ("Sareum" or "the Company") Result of AGM Sareum (AIM: SAR), the specialist cancer drug discovery and development business, announces that at the Company's Annual General Meeting held earlier today, all resolutions were duly passed. For further information: Sareum H...

Fundamental DataMore

EPS-0.04
Dividend yield0 %

Equity Research (SAR)

Sareum Holdings plc
20/02/2017
The specialist cancer drug discovery and development business has reported HY December 2016 results registering a maiden net profit of £573k driven by the licensing deal agreed in September 2016 with...
Sareum Holdings plc
13/01/2017
The specialist cancer drug discovery and development business this week announced the attainment of a US$2m success milestone payment as part of the Chk1 licence agreement between its co-investment...
Sareum Holdings plc
02/11/2016
The specialist cancer drug discovery and development business has announced final results for the year ending 30 June 2016. It is a year that saw the Company get its first clinical trial approvals...

Latest discussion posts More

  • Expectation

    Moved sp 0.2 to about 0.8 US deal and payments up to 1.2 but it has not held.... Deal on spikes...
    31-Mar-2017
    clockwurktangerine
  • Expectation

    Moved sp 0.2 to about 0.8 US deal and payments up to 1.2 but it has not held.... Deal on spikes...
    31-Mar-2017
    clockwurktangerine
  • Re: Another 200% up....

    Up 8% today.@ 1.03p
    1-Mar-2017
    Ripley94

Users' HoldingsMore

Users who hold Sareum Holdings also hold..
RANGE RES.17%
LLOYDS GRP.16%
ROCKHOPPER14%
SOLO OIL13%
SIRIUS MINERALS13%

Codes & Symbols

ISINGB00B02RFS12
SymbolsSAR, LSE:SAR, SAR.L, SAR:LN, LON:SAR, XLON:SAR